Concepedia

Tatsuroh Kaneko

TK

Statistics

Publications

5

Citations

505

H-Index

5

Active since

2018

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (Japan)

Kagoshima University

Tatsuroh Kaneko is an author at Boehringer Ingelheim (Germany) specializing in diabetes mellitus, diabetology, and pharmacotherapy.

ORCID

Publications per year

2018–2024

5

Publications

5

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition

Issei Tomita, Shinji Kume, Sho Sugahara et al. · Cell Metabolism · 2020 · 362 citations · Full text

, , +16

Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes

Atsutaka Yasui, Ganghyuck Lee, Tetsuaki Hirase et al. · Diabetes Therapy · 2018 · 79 citations · Full text

, , +17

Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial

Hirohito Sone, Tatsuroh Kaneko, Kosuke Shiki et al. · Diabetes Obesity and Metabolism · 2019 · 29 citations · Full text

, , +12

Hypothalamic orexinergic neurons modulate pain and itch in an opposite way: pain relief and itch exacerbation

Tatsuroh Kaneko, Tomoyuki Kuwaki, Hideki Kashiwadani · The Journal of Physiological Sciences · 2022 · 21 citations · Full text

, , +16

Orexin neurons play contrasting roles in itch and pain neural processing via projecting to the periaqueductal gray

Tatsuroh Kaneko, Asuka Oura, Yoshiki Imai et al. · Communications Biology · 2024 · 14 citations · Full text

, , +17

1–5 of 5